Insights From Technical Analysis
.webp&w=828&q=75)
Hazer Group (ASX: HZR): Licensing Wins Pile Up as Shares Sit at a Key Support Level
Hazer Group (ASX: HZR) is pushing its capital-light hydrogen and graphite licensing model toward commercial execution, with a FortisBC facility underway and a new Japanese utility study won.
OFX Group (ASX: OFX): Cyber Scare Puts $1 Equals Takeover under the Microscope
OFX Group (ASX: OFX) is probing a cyber incident involving unauthorised data access while its $1 Equals takeover awaits financing, and Funds SA has dropped below the 5% substantial holder threshold.
Caprice Resources (ASX: CRS): Valuing the Gold Before It Becomes a Resource
Caprice Resources (ASX: CRS) is an exploration-stage gold company focused on Western Australia’s Murchison Goldfields. Its Island Gold Project is advancing toward a maiden MRE, supported by high-grade drilling, while valuation remains highly dependent on exploration success and future resource definition.
.webp&w=828&q=75)
Emyria (ASX: EMD): Sydney Clinic Opens as Treatment Network Expands
Emyria (ASX: EMD) has opened its first Sydney Empax clinic, expanding its treatment network to four Australian states. The new facility adds treatment capacity, while patient volumes and reimbursement arrangements remain key factors in its commercial development.
Dateline Resources (ASX: DTR): National Security Case Gives Colosseum Rare Earths Bid New Life
Dateline Resources (ASX: DTR) has gained US Department of War backing in its bid to restart Colosseum, a gold and rare earths project in California, as a key court hearing nears.
Critica (ASX: CRI): Recent Breakout Meets New Fundamental Signals From Mt Lindsay
Critica (ASX: CRI) released a Mt Lindsay Scoping Study showing a $1 billion NPV underground tin-tungsten operation, though shares eased on the day. With funding pathways still being explored, the company continues advancing its Jupiter rare earths project in parallel.